About
Join us for an exciting webinar exploring four groundbreaking abstracts presented at ECTRIMS 2024, highlighting the latest advancements in MS research and treatment.
Our expert panel will delve into landmark advancements in MS management, including the transformative impact of starting high-efficacy treatment early in children. This approach is reshaping how MS is treated and has been shown to significantly reduce long-term disability in paediatric population. Additionally, the experts will explore the potential of emerging biomarkers, such as serum Neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP), which may soon become critical tools in predicting disability progression.
New genetic insights will be uncovered, focusing on ancestry-specific genetic variants linked to MS that could offer fresh perspectives for reshaping treatment strategies. The session will then conclude with an in-depth analysis of treatment decisions for women with MS, emphasizing the need to overcome therapeutic inertia to ensure they receive the most effective and safe treatments at the right time.
Don’t miss this chance to stay at the forefront of MS research and treatment. This is a free webinar, but registration is required.
Register now to secure your spot and be part of the conversation that could shape the future of MS care!
Featured Speakers:
Moderators:
- Frauke Zipp, Germany
- Robert Hoepner, Switzerland
Speakers:
- Ashley Beecham, USA
- Antoine Gavoille, France
- Sifat Sharmin, Australia
- Enric Monreal, Spain